nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2023, 01, v.6 46-52
基于网络药理学探讨苦参治疗阴道炎的作用机制
基金项目(Foundation): 湖北省自然科学基金项目(No:2013CFB387)
邮箱(Email): jialiang822@163.com;
DOI:
摘要:

目的:通过网络药理学方法研究苦参治疗阴道炎的潜在作用靶点及作用机制。方法:运用中药系统药理数据库及分析平台(TCMSP)筛选苦参有效成分及靶点,运用人类孟德尔遗传病数据库(OMIM)、GeneCards数据库收集阴道炎相关靶点。通过微生信筛选出共同靶点,运用String数据库和Cytoscape 3.7.0软件分析蛋白互作关系(PPI)。运用Metascape数据库进行基因本体(GO)生物过程富集分析和京都基因和基因组百科全书(KEGG)代谢通路富集分析,并运用微生信做富集气泡图,最后利用Cytoscape 3.7.0软件作“苦参有效成分-阴道炎-靶点-KEGG”网络构建。结果:苦参可能通过白细胞介素17(IL17)及核转录因子-κB(NF-κB)信号通路对阴道炎发挥治疗作用,作用靶点包括丝裂原活化蛋白激酶1(MAPK1)、血管内皮生长因子(VEGFA)、白细胞介素6(IL6)、基质金属蛋白酶9(MMP9)、基质金属蛋白酶2(MMP2)、白细胞介素4(IL4)以及白细胞介素2(IL2)等。结论:苦参可能作用于IL17及NF-κB信号通路中的MAPK1、VEGFA、IL6、MMP9、MMP2、IL4、IL2靶点而治疗阴道炎。

Abstract:

Objective: To analyze the potential mechanism of Kushen(Radix Sophorae Flavescentis) in the treatment of vaginitis by means of network pharmacology. Methods: The effective components and targets of Kushen were screened by TCMSP database. The relevant targets of vaginitis were collected by OMIM and GeneCards database. The common targets were screened out by Micro Channel. The relationship of protein-protein interaction was analyzed by the String database and Cytoscape 3.7.0 software. The gene ontology(GO), kyoto encyclopedia of genes and genomes(KEGG) metabolic pathway were analysed using Metascape database. The enrichment bubble diagram was worked by Micro Channel. Finally, the network of “active ingredient of Kushen-vaginitis-target-KEGG” was constructed by Cytoscape 3.7.0 software. Results: Kushen may play a therapeutic role in vaginitis through IL17 and NF-κB signaling pathway. The targets include MAPK1, VEGFA, IL6, MMP9, MMP2, IL4, IL2, etc. Conclusion: Kushen may put therapeutic effect on vaginitis dependent on IL17 and NF-κB signaling pathway via targeting MAPK1, VEGFA, IL6, MMP9, MMP2, IL4 and IL2.

参考文献

[1] 国家药典委员会.中华人民共和国药典-四部:2015年版分辑号:四部[M].北京:中国医药科技出版社,2015.

[2] 苏丽丽.苦参的化学成分和药理作用研究进展[J].化学工程师,2021,35(3):58-61.

[3] 郎建玲.易黄止带汤联合苦参凝胶治疗霉菌性阴道炎临床研究[J].新中医,2020,52(5):110-113.

[4] 贾孟彦.苦参凝胶与克林霉素联用对细菌性阴道炎的临床疗效与安全性[J].中国药物与临床,2019,19(21):3765-3766.

[5] 黄艳艳,李莉,朱爱琴.乳酸菌阴道胶囊联合苦参软膏治疗萎缩性阴道炎的疗效分析[J].内蒙古中医药,2019,38(10):105-107.

[6] 李梢.网络药理学评价方法指南[J].世界中医药,2021,16(4):527-532.

[7] 陈曦,李婷,王风娟,等.外阴阴道假丝酵母菌病模型大鼠阴道局部免疫调节的变化[J].中华妇产科杂志,2019,54(5):330-337.

[8] Qu S,Chen L,Tian H,et al.Effect of perillaldehyde on prophylaxis and treatment of vaginal candidiasis in a murine model[J].Front Microbiol,2019,10:1466.

[9] Li W,Shi W Y,Yin Y J,et al.Association of IL-17 and IL-23 gene variants with plasma levels and risk of vulvovaginal candidiasis in a Chinese Han population[J].Pharmacogenomics Pers Med,2020,13:725-733.

[10] Monin L,Gaffen S L.Interleukin 17 family cytokines:signaling mechanisms,biological activities,and therapeutic implications[J].Cold Spring Harb Perspect Biol,2018,10(4):a028522.

[11] Gao Q,Liu Y,Wu Y,et al.IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB[J].Int J Mol Med,2016,37(2):347-358.

[12] Amatya N,Garg A V,Gaffen S L.IL-17 signaling:the Yin and the Yang[J].Trends Immunol,2017,38(5):310-322.

[13] McGeachy M J,Cua D J,Gaffen S L.The IL-17 family of cytokines in health and disease[J].Immunity,2019,50(4):892-906.

[14] Beringer A,Noack M,Miossec P.IL-17 in chronic inflammation:from discovery to targeting[J].Trends Mol Med,2016,22(3):230-241.

[15] Mitchell J P,Carmody R J.NF-κB and the transcriptional control of inflammation[J].Int Rev Cell Mol Biol,2018,335:41-84.

[16] Sun S C.The non-canonical NF-kappaB pathway in immunity and inflammation[J].Nat Rev Immunol,2017,17(9):545-558.

[17] Kim D E,Kim J K,Han S K,et al.Lactobacillus plantarum NK3 and Bifidobacterium longum NK49 alleviate bacterial vaginosis and osteoporosis in mice by suppressing NF-κB-linked TNF-α expression[J].J Med Food,2019,22(10):1022-1031.

基本信息:

中图分类号:R285

引用信息:

[1]胡月琴,贾亮亮.基于网络药理学探讨苦参治疗阴道炎的作用机制[J].巴楚医学,2023,6(01):46-52.

基金信息:

湖北省自然科学基金项目(No:2013CFB387)

投稿时间:

2021-03-10

投稿日期(年):

2021

终审时间:

2021-07-02

终审日期(年):

2021

修回时间:

2021-05-18

审稿周期(年):

1

发布时间:

2023-03-28

出版时间:

2023-03-28

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文
检 索 高级检索